Heme oxygenase promotes B‐Raf‐dependent melanosphere formation

Authors:
Publisher website
Google Scholar
Abstract
Biosynthesis and degradation of heme, an iron‐bound protoporphyrin molecule utilized by a wide variety of metabolic processes, are tightly regulated. Two closely related enzymes, heme oxygenase 1 (HMOX1) and heme oxygenase 2 (HMOX2), degrade free heme to produce carbon monoxide, Fe2+, and biliverdin. HMOX1 expression is controlled via the transcriptional activator, NFE2L2, and the transcriptional repressor, Bach1. Transcription of HMOX1 and other NFE2L2‐dependent genes is increased in response to electrophilic and reactive oxygen species. Many tumor‐derived cell lines have elevated levels of NFE2L2. Elevated expression of NFE2L2‐dependent genes contributes to tumor growth and acquired resistance to therapies. Here, we report a novel role for heme oxygenase activity in melanosphere formation by human melanoma‐derived cell lines. Transcriptional induction of HMOX1 through derepression of Bach1 or transcriptional activation of HMOX2 by oncogenic B‐RafV600E results in increased melanosphere formation. Genetic ablation of HMOX1 diminishes melanosphere formation. Further, inhibition of heme oxygenase activity with tin protoporphyrin markedly reduces melanosphere formation driven by either Bach1 derepression or B‐RafV600E expression. Global transcriptome analyses implicate genes involved in focal adhesion and extracellular matrix interactions in melanosphere formation.
Funding Information
  • U.S. Department of Education (GAANN IX P200A100178)
  • National Institutes of Health (NIH 1 P50 AT006273)

This publication has 118 references indexed in Scilit: